Study Stopped
The recruitment was stopped due to province-wide lockdown secondary to COVID-19. Blood pressure screenings were conducted in community centres and due to province wide lockdown, further screenings could not be continued.
South Asian Low-sodium Trial
SALT
1 other identifier
interventional
23
1 country
1
Brief Summary
The overall goal of this pilot study is to examine the feasibility and acceptability of a culturally-tailored low-sodium dietary intervention is South Asian Canadians with stage one HTN. Specific objectives are to determine the feasibility (recruitment, retention, engagement and acceptability) of this intervention. Secondary outcomes include the effect of low-sodium dietary intervention on knowledge, attitude and self-regulation behaviours. Exploratory outcomes include its effect of systolic, diastolic blood pressure and sodium intake. Information obtained from this pilot trial will inform design of a larger randomized controlled trial in reducing BP in South Asian Canadians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Aug 2019
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2020
CompletedFirst Submitted
Initial submission to the registry
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
November 30, 2021
CompletedNovember 30, 2021
November 1, 2021
8 months
October 15, 2021
November 15, 2021
Conditions
Outcome Measures
Primary Outcomes (15)
Recruitment
Number of eligible participants agreeing to participate compared to total eligible participants
End of study-6 weeks
Retention
Number of participants who complete follow-up assessment at 6-weeks.
Through study completion-6 weeks
Intervention Engagement with the SALT Intervention Manual
Number of participants in the intervention group who read the manual in its entirety
Through study completion, 6-weeks
Intervention Engagement with five weekly online modules
Number of participants in the intervention group who complete the five weekly online modules
Through study completion, 6-weeks
Intervention Engagement with five weekly goal-setting worksheets
Number of participants in the intervention group who complete the five goal-setting worksheets
Through study completion, 6-weeks
Intervention Engagement with five weekly telephone calls
Number of participants in the intervention group who complete the five weekly telephone calls
Through study completion, 6-weeks
Intervention Acceptability Questionnaire
Intervention Acceptability (Likert scale): Minimum Score: 0 and Maximum Score: 40, Higher score indicate higher acceptability
Through study completion, 6-weeks
Intervention Acceptability-1
Ease of reading SALT-Intervention Manual
Through study completion, 6-weeks
Intervention Acceptability-2
Ease of using goal-setting worksheets
Through study completion, 6-weeks
Intervention Acceptability-3
Ease of using online modules
Through study completion, 6-weeks
Intervention Acceptability-4
Ease of viewing cooking demonstration
Through study completion, 6-weeks
Intervention Acceptability-6
Ease of attending weekly telephone calls
Through study completion, 6-weeks
Intervention Acceptability-7
Encouragement to reduce sodium
Through study completion, 6-weeks
Intervention Acceptability-8
Satisfaction with time to complete study components
Through study completion, 6-weeks
Intervention Acceptability
Overall satisfaction with the study
Through study completion, 6-weeks
Secondary Outcomes (3)
Secondary outcome 1: Knowledge related to dietary sodium
At baseline and at 6-weeks
Secondary outcome 2: Attitudes related to dietary sodium
At baseline and at 6-weeks
Secondary outcome 3: Behaviours related to dietary sodium
At baseline and at 6-weeks
Other Outcomes (3)
Exploratory outcomes-1
At baseline and at completion of the study-6 weeks
Exploratory outcomes-2
At baseline and at completion of the study-6 weeks
Exploratory outcomes-3
At baseline and at completion of the study-6 weeks
Study Arms (2)
Intervention Group
EXPERIMENTALThe intervention group will receive the standard care in the form of HTN Canada Booklet, advice to see their health care provider, urgent care or walk-in clinic and the Salt Intervention (Salt Intervention Manual, five weekly online modules and five weekly telephone calls.
Usual Care Group
NO INTERVENTIONAll participants in the usual care group will receive the standard care in the form of HTN Canada Booklet, advice to see their health care provider, urgent care of walk-in clinic.
Interventions
Participants in the intervention group will have access to all standard care as provided to the usual care group participants. In addition, participants in the intervention group will receive the SALT-intervention developed by the principal investigator in the form of a SALT-intervention consist of the Salt Intervention manual, five online modules which include a virtual cooking demonstration and five ten-minute weekly telephone calls delivered by the principal investigator.These strategies aim to increase knowledge, enhance self-management abilities and provide social support.
Eligibility Criteria
You may qualify if:
- South Asian individuals (India, Pakistan, Srilanka, Bangladesh, Nepal and Bhutan) over the age of 18 years
- Stage one HTN, systolic BP of 140-159 mmHg or diastolic BP of 90-99 mmHg at baseline and not on anti-hypertensive medications
- Consuming a daily sodium intake of \>2000 mg/24 hours as determined at baseline by an online Salt Calculator,
- Able to read, understand and write English
- Access to computer with internet capabilities and a telephone
You may not qualify if:
- Use of anti-hypertensive medications
- Use of herbal or over-the counter medications to control BP
- Use of insulin or oral hypoglycemic agents
- Have an active cancer diagnosis or on treatment during the past three months due to interference between diet and cancer treatment
- Have special dietary requirements and unable to consume a self-selected diet
- Are pregnant, breastfeeding or anticipate pregnancy prior to the end of the study
- Individuals who plan to leave the area prior to the anticipated end of study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Social Services Network
Markham, Ontario, L3P 2T4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Salima Hemani, RN, PhD C.
University of Toronto, Lawrence S. Bloomberg Faculty of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The principal investigator will be responsible for randomization and the outcome assessor (research assistant) will be blinded to group allocation. The research assistant will collect all outcome data at 6 weeks from the intervention and usual care group.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 15, 2021
First Posted
November 30, 2021
Study Start
August 27, 2019
Primary Completion
April 29, 2020
Study Completion
April 29, 2020
Last Updated
November 30, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share
All data will be completely confidential and will not be shared with other researchers.